Vape flavoring chemicals and oral fibroblast viability
Abstract
The widespread use of electronic cigarettes is due to the variety of appealing flavor additives marketed to consumers. Although perceived as a less harmful alternative to traditional smoking, emerging evidence suggests that inhaled e-cigarettes aerosol poses multiple risks on oral health. Oral fibroblasts which maintain the extracellular matrix and support wound repair, may be vulnerable to chemical injury. While the toxic effects of base e-liquid components such as nicotine have been investigated, limited research has addressed how added flavoring chemicals influence oral fibroblast survival and stress responses. A comprehensive search was conducted across PubMed, ScienceDirect, and Google Scholar to identify peer-reviewed studies evaluating the biological impact of flavored e-cigarette exposure on human oral fibroblasts. Collective findings revealed consistent mechanistic trends: flavoring chemicals, especially aromatic aldehydes such as cinnamaldehyde and vanillin, induced adverse cellular responses, increasing intracellular reactive oxygen species, and triggering oxidative modifications. These oxidative injuries such as protein carbonylation promote pro-inflammatory responses in oral fibroblasts, specifically heightened secretion of cytokine interleukin-8 and lipid mediator prostaglandin E2, which contribute to tissue breakdown. Increased apoptosis, impaired cell survival, and senescence were reported following longer exposure durations. In contrast, menthol and fruit…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.